A fatal case of myocardial damage due to misuse of the "designer drug" MDMA

Legal Medicine

Volumn 11, Issue 6, 2009, Pages 294-297

  Sano, Rie ^a   Hasuike, Toshikazu ^b   Nakano, Minoru ^b   Kominato, Yoshihiko ^a   Itoh, Hideaki ^b  

^a GUNMA UNIVERSITY   (Japan)

^b MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

MDMA; Myocardial damage; Myoglobinuria

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; BLOOD LEVEL; BRONCHOPNEUMONIA; CARDIOTOXICITY; CASE REPORT; FATALITY; FEMALE; HEART; HEART MUSCLE INJURY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; LUNG; MEDULLA OBLONGATA; MYOGLOBINURIA; NERVE CELL DEGENERATION; PONS;

ADULT; AUTOPSY; BRAIN; FATAL OUTCOME; FEMALE; HEART; HUMANS; KIDNEY; LIVER; MYOCARDIUM; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE-RELATED DISORDERS;

EID: 70350742993     PISSN: 13446223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.legalmed.2009.09.003     Document Type: Article

References (11)

1. In: Baselt R.C. (Ed). Disposition of toxic drugs and chemicals in man: methylenedioxymethamphetamine. 7th ed. (2004), Biomedical Publications, Foster City 723-725
2. Milroy C.M., Clark J.C., and Forrest A.R.W. Pathology of deaths associated with "ecstasy" and "eve". J Clin Pathol 49 (1996) 149-153
3. Ellis A.I., Wendon J.A., Portmann B., and Williams R. Acute liver damage and Ecstasy ingestion. Gut 38 (1996) 454-458
4. Greene S.L., Dargan P.I., O'connor N., Jones A.L., and Kerins M. Multiple toxicity from 3,4-methylenedioxymethamphetamine ("Ecstasy"). Am J Emerg Med 21 (2003) 121-124
5. Henry J.A., Jeffreys K.J., and Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 340 (1992) 384-387
6. Kalant H. The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165 (2001) 917-928
7. Varner K.Y., Delcarpio J.B., and Moerschbaecher J.M. Cardiac toxicity elicited by repeated administration of 3,4-methylenedioxymethamphetamine (MDMA). NIDA Res Monogr 179 (1998) 214
8. Carvalho M., Remião F., Milhazes N., Borges F., Fernandes E., Monteiro M.C., et al. Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Chem Res Toxicol 17 (2004) 623-632
9. Klys M., Rojek S., Woźniak K., and Rzepecka-Woźniak E. Fatality due to the use of a designer drug MDMA (Ecstasy). Leg Med 9 (2007) 185-191
10. Martin T.L., Chiasson D.A., and Kish S.J. Does hyperthyroidism increases risk of death due to the ingestion of Ecstasy?. J Forensic Sci 52 (2007) 951-953
11. Tuker G.T., Lennard M.S., Ellis S.W., Woods H.F., Cho A.K., Lin L.Y., et al. The demethylation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol 47 (1994) 1151-1156